4
Changes in Ownership
SpyGlass Pharma, Inc. Filed Acc 0001427569-26-000008
Options or other derivatives
- Chief Financial Officer acquired 17,500 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Viret Jean-Frederic · Chief Financial Officer
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2026-02-05 | Grant or award : show line 1 in the form Stock Option (right to buy) | +17,500 | 17,500 | D |
Loading xslF345X05/form4-02092026_090235.xml…